Nov 1(Reuters) - BIOPHYTIS ALBPS.PA :
* ANNOUNCED ON MONDAY CASH POSITION AT EUR 19.7 MILLION AT
JUNE
30, 2022 COMPARED TO EUR 23.9 MILLIONS AS OF DECEMBER 31, 2021
* H1 OPERATING LOSS OF EUR 11.9 MILLION COMPARED TO LOSS OF
EUR
10.5 MILLION YEAR AGO
* CASH USED BY OPERATING ACTIVITIES DOWN 23% WITH EUR 10.3
MILLION
USED IN H1 2022 COMPARED TO EUR 13.4 MILLION IN H1 2021
* FINANCIAL STATEMENTS FOR YEAR ENDED DEC 31, 2021 WILL BE
RESTATED TO CORRECT ACCOUNTING TREATMENT OF KRÉOS FINANCING
CONTRACT SIGNED IN NOVEMBER 2021
* RESTATEMENT EXPECTED TO HAVE MINOR IMPACT ON INCOME
STATEMENT
AND CASH FLOW STATEMENT FOR 2021, AND ON KEY FINANCIAL DATA AT
JUNE 30, 2022
Source text for Eikon: urn:newsml:reuters.com:*:nACSpWXjVa
Further company coverage: ALBPS.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))